SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer.
Condition:   Breast Cancer Intervention:   Drug: SHR6390+anatrozole Sponsors:   Tianjin Medical University Cancer Institute and Hospital;   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2021 Category: Research Source Type: clinical trials